BRII-5395: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Advanced HBV-Related Hepatocellular Carcinoma	1
Hepatitis B	1

Recruiting trials involving BRII-5395

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
NCT07557251 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve BRII-5395?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.